Your browser doesn't support javascript.
loading
Humanized anti-IL-26 monoclonal antibody as a novel targeted therapy for chronic graft-versus-host disease.
Hatano, Ryo; Itoh, Takumi; Otsuka, Haruna; Saeki, Harumi; Yamamoto, Ayako; Song, Dan; Shirakawa, Yuki; Iyama, Satoshi; Sato, Tsutomu; Iwao, Noriaki; Harada, Norihiro; Aune, Thomas M; Dang, Nam H; Kaneko, Yutaro; Yamada, Taketo; Morimoto, Chikao; Ohnuma, Kei.
Afiliación
  • Hatano R; Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Itoh T; Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Otsuka H; Atopy (Allergy) Research Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Saeki H; Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Yamamoto A; Department of Human Pathology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Song D; Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Shirakawa Y; Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Iyama S; Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Sato T; Department of Hematology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
  • Iwao N; Department of Hematology, Toyama University Hospital, Toyama, Japan.
  • Harada N; Department of Hematology, Juntendo University Shizuoka Hospital, Shizuoka, Japan.
  • Aune TM; Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.
  • Dang NH; Department of Medicine, Vanderbilt University School of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Kaneko Y; Division of Hematology/Oncology, University of Florida, Gainesville, Florida, USA.
  • Yamada T; Y's AC Co., Ltd., Tokyo, Japan.
  • Morimoto C; Department of Pathology, Saitama Medical University, Saitama, Japan.
  • Ohnuma K; Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
Am J Transplant ; 22(12): 2804-2820, 2022 12.
Article en En | MEDLINE | ID: mdl-35997569
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Am J Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Am J Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos